Study of oxidative stress in pre- and post-hemodialysis in chronic renal failure patients

Biomedical Research (India)

Volumn 24, Issue 4, 2013, Pages 498-502

  Nagane, N S ^a   Ganu, J V ^b   Jagtap, P E ^a  

^a BHARATI VIDYAPEETH UNIVERSITY   (India)

^b Govt Medical College Miraj   (India)

Author keywords

Chronic renal failure (CRF); Hemodialysis (HD); High sensitivity C reactive protein (hs CRP); Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; INFLAMMATION; LIPID PEROXIDATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL;

EID: 84886926588     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wever R, Boer P, Hijmering M, Stores E, Verhaar M, Kastelein J, Varsluis K. Nitric oxide production is reduced in patients with chronic renal failure. Arterio-sclerosis, Thrombosis, and Vascular Biology 1999; 19:1168-1172.
2. Cruz DN, Soni SS, Polanco N, Bobek I, Corradi V, Cal MD, Rohco C. Markers of inflammation and oxidative stress in periotoneal dialysis: a comparison between high and low peritoneal transporters. J Nephrol 2010; 23(4): 453-458.
3. Locatelli F, Bommer J, London GM, Martin-Malo A, Wanner C, Yaqoob M. Cardiovascular disease determinants in chronic renal failure: Clinical approach and treatment. Nephrol Dial Transplant 2005; 16: 459-468.
4. Bitla AR, Reddy PE, Manohar SM, Vishnubhotla SV, Srinivasa Rao PVLN. Effect of a single hemodialysis session on inflammatory markers. Hemodialysis International 2010; 14(4): 411-417.
5. Reddy EP, Suchitra MM, Bitla AR, Sivakumar V, Srinivasa Rao PVLN. Antioxidant enzymes status in south Indian hemodialysis patients. Int J Biol Med Res. 2011; 2(3): 682-687.
6. El-Khawaga O.Y and El-Sayed I.H. Evaluation of trace elements and antioxidants in pre and post hemodi-alysis of chronic renal failure patients. International Journal of Science and Nature 2012; 3(3): 617-6
7. Clermont G, Lecour S, Lahet J, Siohan P, Vergely C, Chevet D. Alteration in plasma antioxidant capacities in chronic renal failure and cardiovascular risk in these patients. Cardiovascular Research 2000; 47: 618-623.
8. Aiello S, Noris M, Remuzzi G. Nitric Oxide/ L-arginine in uremia. Mineral Electrolyte Metab 1999; 25: 384-390.
9. Wang AY, Woo J, Lam CW. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2003; 14: 1871-1879.
10. th ed. Missouri: Elsevier; 2006:1671-1725.
11. Tarakcroglu E, Binnur A, Erbagic, Usalan C, Deveci R and Kocabas R. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators of Inflammation 2003; 12: 15-19.
12. Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nichols K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ. Cardiovascular morbidity and mortality in the atherosclerosis and folic acid supplementation trial (ASFAST) in chronic renal failure. Journal of the American Collegge of Cardiol-ogy 2006; 47(6): 1108-1116.
13. Moustapha A, Naso A, Nahlwai M, Gupta A, Arheart KL, Jacobsen DW. Prospective study of hyperhomo-cysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998, 97: 138-141.
14. Jackson P, Loughrey CM, Lightbody J H, Mc Namee PT, Young IS. Effect of haemodialysis on total anti-oxidant capacity and serum antioxidant in patients with chronic renal failure. Clin Chem 1995; 41(8), 1135-1138.
15. Durak I, Akyol O, Basesme E, Canbolat O, Kavutcu M. Reduced defence mechanism against free radical toxic-ity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
16. National kidney foundation. K/DOQRI: clinical practice guidelines for chronic kidney disease: evaluation classification, and stratification Kidney Disease outcome Quality Initiative. Am J kidney Dis. 2002;39:1-246.
17. Levey AS, Bosch JP, Lewis JB, Green T, Rogers N, Roth D. A more accurate method to estimate glomeru-lar filteration rate from serum creatinine: a new prediction equation modification of diet in renal disease study group. Ann Intern Med 1999; 130(6): 461-470.
18. Satoh K. Plasma lipid peroxide in cerebrovascular disorder determined by a new colorimetric method. Clinica Chimica Acta 1978; 90: 37-43.
19. Nischal HK, Sharma MP, Goyal RK, Kaushik GG. Serum superoxide dismutase levels in diabetes mellitus with or without microangiopathic complications. JAPI 1998; 46:853-855.
20. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmimum method. Clin Chem 1990; 36(8):1440-1443.
21. Estimation of homocysteine by automated chemilumi-nescence's Bayer Health Care (Company System Manual).
22. Chenilot O. Clin Chem Lab Med 2000; 38: 1003-1011.
23. Varan HI, Dursun B, Dursun E, Ozben T, Suleymanlar G. Acute effects of hemodialysis on oxi-dative stress parameters in chronic uremic patients: Comparision of two dialysis membranes. International Journal of Nephrology and Renovascular Disease 2010: 3; 39-45.
24. Tarng DC, Huang TP, Wei YH, Lin TY, Chen HW, Wen Chen T. 8-Hidroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 2000; 36(5): 934-944.
25. Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001;12:2747-2752.
26. Miric D, Kisic B, Stolic R, Miric B, Mitic R and Janici-jevic-Hudomal S. The role of Xanthine oxidase in hemodialysis-induced oxidative injury: Relationship with Nutritional status. Oxidative Medicine and Cellular Longevity 2013;1-8.
27. Nouri M, Nober MR, Argani H, Rokhforooz Superox-ide dismutase and glutathione peroxide in hemodia-lyzed patients and renal transplant recipients and their relationship to osmotic fragility. Medical Journal of Islamic Academy of Sciences 1999; 12(2): 33-38.
28. Demirtas S, Nergisoglu G, Akbay A, Karaca L. The relation between low-density lipoprotein (LDL) oxidation and hemodialysis with respect to membrane types. Turk J Med Sci 2002; 32: 93-100.
29. Meerashivashekar W, Ebenezer W, Revathi R, Padmanabhan. Effect of oxidative stress in pre and post hemodialysis in chronic renal failure patients. Int J Biol Med Res. 2012; 3(1): 1335-1337.
30. Ramprasad N and Al-Ghoniam Mohammed I. Role of trace elements and lipid peroxidation levels in pre and post hemodialysis of chronic renal failure patients. International Journal of Research in Biochemistry and Biophysics 2013; 3(1): 1-6.
31. Shelgikar PJ, Deshpande KH, Sardeshmukh AS, Kat-kam RV, Suryakar AN. Role of oxidants and antioxi-dants in ARF patients undergoing hemodialysis. Indian J Nephrol 2005, 15:73-76.
32. Sperschneider H, Deppisch R, Beck W, Wolf H, Stein G. Impact of membrane choice and blood flow pattern on Coagulation and heparin requirement- potential consequences on lipid concentration. Nephrol Dial Transplant 1997; 12:2638-2646.
33. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 2000; 58: 1261-1266.
34. Cross JM, Donald A, Vallance PJ, Deanfield JE, Woolfson RG, Macallister RJ. Dialysis improves en-dothelial function in humans. Nephrol Dial Transplant 2001; 16: 1823-1829.
35. Filiopoulos V and Vlassopoulos D. Inflammatory syndrome in chronic kidney disease: Pathogenesis and influence on outcmes. Inflammation and Allergy- Drug Target 2009;8: 369-382.
36. Massy ZA. Potential strategies to normalize the levels of homocysteine in chronic renal failure patients. Kidney Int. 2003; 63:134-136.
37. Nakou ES, Elisaf MS and Liberopoulos EN. High-Sensitivity C-Reactive Protein: to measure or not to measure? The Open Clinical Chemistry Journal 2010;3:10-18.
38. Suliman ME, Stenvinkel P. Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi J Kidney Dis Transplant 2008; 19(3): 329-345.
39. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16(11): 2240-2245.
40. Calearfield MB. C-Reactive protein: A new risk assessment tool for cardiovascular Disease. JAOA. 2005; 105(9):409-416.